Loading asset research
Jyong Biotech Ltd. Ordinary Shares
MENSNasdaq · USD · StocksQuote as of · Exchange session not verified$1.99
-1.00%
Today
MENS
Loading 1D prices…
Market cap
$151.3M
Volume
45.4K
52w high
$67.0052w low
$1.43Company profile
Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
New Taipei City, United States
Employees
27
CIK
1954488
Session & valuation
Open$1.98
Previous close$2.01
Day high$2.06
Day low$1.98
30-day avg. volume39.3K
Outstanding shares76M
Diluted EPS-$0.06
Latest annual period
P/E (trailing)-33.17
P/E (forward)—
Price / book-5.92
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OGIOrganigram Global Inc. Common Shares | $151.4M | — | — | -$0.194 | -1.87% | Buy |
| SPRBSpruce Biosciences Inc. Common Stock | $154.3M | $0.00 | — | -$50.83 | -1.20% | Buy |
| NRXPNRX Pharmaceuticals Inc. Common Stock | $147.2M | $1.2M | -2336.49% | -$1.34 | +0.15% | Hold |
| IMUXImmunic Inc. Common Stock | $155.8M | $0.00 | — | -$0.62 | -3.55% | Buy |
| LFCRLifecore Biomedical Inc. Common Stock | $156M | $128.9M | -30.04% | -$1.27 | +0.73% | Buy |